The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments
Abstract
This paper describes the AACTG Adherence Instruments, which are comprised of two self-report questionnaires for use in clinical trials conducted by the Adult AIDS Clinical Trials Group (AACTG). The questionnaires were administered to 75 patients at ten AACTG sites in the USA. All patients were taking combination antiretroviral therapy (ART), including at least one protease inhibitor. Eleven per cent of patients reported missing at least one dose the day before the interview, and 17% reported missing at least one dose during the two days prior. The most common reasons for missing medications included 'simply forgot' (66%) and a number of factors often associated with improved health, including being busy (53%), away from home (57%) and changes in routine (51%). Less adherent patients reported lower adherence self-efficacy (p = 0.006) and were less sure of the link between non-adherence and the development of drug resistance (p = 0.009). They were also more likely to consume alcohol, to be employed outside the home for pay and to have enrolled in clinical trials to gain access to drugs (all p < 0.05). Twenty-two per cent of patients taking drugs requiring special instructions were unaware of these instructions. Each questionnaire took approximately ten minutes to complete. Responses to the questionnaires were favourable. These questionnaires have been included in six AACTG clinical trials to date and have been widely disseminated to investigators both in the USA and abroad.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The VIRAHEP-C self-efficacy measure was a 24-item self-report measure adapted from previously validated self-efficacy measures created for the Adult AIDS Clinical Trials Group (see Appendix A for the original VIRAHEP-C measure) (19;39) (personal communication, S. Smith, Nov. 11, 2010).”
From Reliability and validity of a self‐efficacy instrument for hepatitis C antiviral treatment regimens (2012) · cites this paper as [39]
Citations
Cites
A Global Measure of Perceived Stress
Cohen, S., Kamarck, T., & Mermelstein, R. (1983) · Journal of Health and Social Behavior · doi:10.2307/2136404 · Cited by 32,807
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,393
Hesselbart, S., & Fowler, F. J. (1985) · Journal of the American Statistical Association · doi:10.2307/2288598 · Cited by 4,767
Haynes, R. B., Taylor, D. W., & Sackett, D. L. (1979) · DigitalGeorgetown (Georgetown University Library) · Cited by 1,627
Mirowsky, J., & Ross, C. E. (1992) · Journal of Health and Social Behavior · doi:10.2307/2137349 · Cited by 856
Hecht, F. M., Grant, R. M., Petropoulos, C. J., Dillon, B. A., Chesney, M. A., Tian, H., Hellmann, N. S., Bandrapalli, N. I., Digilio, L., Branson, B. M., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390504 · Cited by 443
Self-citationPatient Compliance and Drug Failure in Protease Inhibitor Monotherapy
Vanhove, G. F. (1996) · JAMA · doi:10.1001/jama.1996.03540240033024 · Cited by 193
Protease Inhibitors in the Homeless
Bangsberg, D. R. (1997) · JAMA · doi:10.1001/jama.1997.03550010077044 · Cited by 150
Besch, C. L. (1995) · AIDS · doi:10.1097/00002030-199501000-00001 · Cited by 148
Predictors of patient adherence: Patient characteristics.
Dunbar, J. (1990) · Cited by 83
Cited by
Sorted by citations
Items 601–700 of 1,001
Fekete, E. M., Antoni, M. H., Lopez, C. R., Durán, R. E., Penedo, F. J., Bandiera, F. C., FLETCHER, M. A., Klimas, N. G., Kumar, M., & Schneiderman, N. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.01.007 · Cited by 35
for the ANRS 12249 TasP Group, Orne‐Gliemann, J., Larmarange, J., Boyer, S., Iwuji, C. C., McGrath, N. M., Bärnighausen, T., Zuma, T., Dray‐Spira, R., Spire, B., et al. (2015) · BMC Public Health · doi:10.1186/s12889-015-1344-y · Cited by 36
“– In addition to the assessment of adherence during the clinic-follow-up based on visual analogue scale, pill identification test and pill count [44], we assess self-reported adherence using a scale, validated in another African country context, designed to limit both recall and social desirability bias [45-48].”
MethodNemes, M. I. B., Helena, E. T. D. S., Caraciolo, J. M. D. M., & Basso, C. R. (2009) · Cadernos de Saúde Pública · doi:10.1590/s0102-311x2009001500005 · Cited by 35
Measuring medication adherence in asthma: Development of a novel self-report tool
Dima, A. L., Ganse, E. H. V., Laforest, L., Texier, N., de Bruin, M., & the ASTRO-Lab group (2017) · Psychology and Health · doi:10.1080/08870446.2017.1290248 · Cited by 39
Cho, H., Sanabria, G., Saylor, M., Gradilla, M., & Schnall, R. (2019) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2019.08.009 · Cited by 35
Patton, D. E., Woods, S. P., Franklin, D., Cattie, J. E., Heaton, R. K., Collier, A. C., Marra, C. M., Clifford, D. B., Gelman, B. B., McArthur, J. C., et al. (2012) · AIDS and Behavior · doi:10.1007/s10461-012-0237-7 · Cited by 35
Side effect and disease related symptom representations among HIV+ adults on antiretroviral therapy
Johnson, M., & Folkman, S. (2004) · Psychology Health & Medicine · doi:10.1080/13548500410001670672 · Cited by 35
“The AIDS Clinical Trials Group (ACTG) self-report adherence measure was used to assess pills and doses skipped in the last 3 days for each HAART medication (Chesney et al., 2000).”
MethodMcDonald, C., Uy, J. P., Hu, W., Wirtz, V., Juethner, S., Butcher, D. L., McGrath, D., Farajallah, A., & Moyle, G. J. (2012) · AIDS Patient Care and STDs · doi:10.1089/apc.2011.0092 · Cited by 35
Wu, P., Johnson, B. A., Nachega, J. B., Wu, B., Ordóñez, C. E., Hare, A. Q., Kearns, R., Murphy, R. A., Sunpath, H., & Marconi, V. C. (2014) · Current HIV Research · doi:10.2174/1570162x1205141121102501 · Cited by 35
“The possible factors that were considered to have an association with VF were included in the model [9, 35].”
BackgroundMethodInfluentialSauceda, J. A., Wiebe, J. S., & Simoni, J. M. (2014) · Journal of Health Psychology · doi:10.1177/1359105314546341 · Cited by 35
“that normalizes adherence difficulties prefaced the administration of the VAS (Chesney et al., 2000).”
BackgroundInfluentialZwikker, H. E., van den Bemt, B. J. F., Vriezekolk, J. E., van den Ende, C. H. M., & van Dulmen, S. (2014) · Patient Preference and Adherence · doi:10.2147/ppa.s47290 · Cited by 34
Badiee, J., Riggs, P. K., Rooney, A. S., Vaida, F., Grant, I., Atkinson, J. H., & Moore, D. J. (2012) · AIDS Patient Care and STDs · doi:10.1089/apc.2011.0447 · Cited by 32
Haug, N. A., Sorensen, J. L., Lollo, N., Gruber, V. A., Delucchi, K., & Hall, S. M. (2005) · AIDS Care · doi:10.1080/09540120500100882 · Cited by 34
“(adapted from Chesney et al., 2000) is a self-report of patient’s adherence yesterday and the past 2 /4 days for each medication in their current regimen.”
BackgroundOldenmenger, W. H., Echteld, M. A., de Wit, R., Smitt, P. A. E. S., Stronks, D. L., Stoter, G., & van der Rijt, C. C. D. (2007) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2007.01.015 · Cited by 34
Samet, J. H., Raj, A., Cheng, D. M., Blokhina, E., Bridden, C., Chaisson, C. E., Walley, A. Y., Palfai, T. P., Quinn, E. K., Zvartau, E., et al. (2015) · Addiction · doi:10.1111/add.12716 · Cited by 33
Saberi, P., Neilands, T. B., Vittinghoff, E., Johnson, M. O., Chesney, M. A., & Cohn, S. E. (2015) · AIDS Patient Care and STDs · doi:10.1089/apc.2014.0255 · Cited by 33
Self-citationOxytocin, Social Support, and Sleep Quality in Low-Income Minority Women Living With HIV
Fekete, E. M., Seay, J., Antoni, M. H., Mendez, A. J., FLETCHER, M. A., Szeto, A., & Schneiderman, N. (2013) · Behavioral Sleep Medicine · doi:10.1080/15402002.2013.791297 · Cited by 33
“Number of months post-HIV diagnosis was measured through self-report, and medication adherence was also measured via self-report using the Adult AIDS Clinical Trial Group Adherence to Combination Therapy Guide (Chesney et al., 2000).”
MethodMagidson, J. F., Blashill, A. J., Safren, S. A., & Wagner, G. J. (2014) · AIDS and Behavior · doi:10.1007/s10461-014-0802-3 · Cited by 33
Smith, K. Y., Tierney, C., Mollan, K. R., Venuto, C. S., Budhathoki, C., Ma, Q., Morse, G. D., Sax, P., Katzenstein, D. A., Godfrey, C., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit747 · Cited by 33
“to men on ATV/r based upon a validated self-report questionnaire [16].”
MethodMizuno, Y., Beer, L., Huang, P., & Frazier, E. L. (2017) · LGBT Health · doi:10.1089/lgbt.2017.0003 · Cited by 34
Brittain, K., Remien, R. H., Mellins, C. A., Phillips, T. K., Zerbe, A., Abrams, E. J., & Myer, L. (2018) · AIDS Care · doi:10.1080/09540121.2018.1503637 · Cited by 33
Nichols, J. S., Kyriakides, T. C., Antwi, S., Renner, L. A., Lartey, M. Y., Seaneke, O. A., Obeng, R., Catlin, A. C., Gan, G., Reynolds, N. R., et al. (2018) · AIDS Care · doi:10.1080/09540121.2018.1524113 · Cited by 33
“…(1) caregiver three-day recall using a modified version of the selfreport questionnaire developed by the Adult AIDS Clinical Trials Group (AACTG) (Chesney et al., 2000; Duong et al., 2001); (2) child three-day recall; and (3) pharmacybased time-to-refill of ART (Ernesto et al., 2012;…”
MethodMarcellin, F., Spire, B., Carrieri, M., & Roux, P. (2013) · Expert Review of Anti-Infective Therapy · doi:10.1586/eri.13.8 · Cited by 34
Mendelsohn, J., Schilperoord, M., Spiegel, P., Balasundaram, S., Radhakrishnan, A., Lee, C. K. C., Larke, N., Grant, A., Sondorp, E., & Ross, D. (2013) · Aids and Behavior · doi:10.1007/s10461-013-0494-0 · Cited by 35
“Key self-reported adherence measures included a retrospective four-day dose-by-dose recall [10] and a retrospective one-month general recall measured on a visual analogue scale (VAS) [11].”
Fekete, E. M., Geaghan, T. R., & Druley, J. A. (2008) · Psychology and Health · doi:10.1080/08870440801894674 · Cited by 33
“Items for this scale were adapted from the General Health Behaviours measure developed by the Adult AIDS Clinical Trials Group (AACTG; Chesney et al., 2000).”
MethodBianco, J. A., Heckman, T. G., Sutton, M., Watakakosol, R., & Lovejoy, T. I. (2010) · AIDS and Behavior · doi:10.1007/s10461-010-9756-2 · Cited by 33
Garvey, L. J., Nelson, M. R., Latch, N., Erlwein, O. W., Allsop, J. M., Mitchell, A. A., Kaye, S., Watson, V., Back, D. J., Taylor-Robinson, S. D., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr427 · Cited by 33
Crane, H. M., Crane, P. K., Tufano, J. T., Ralston, J. D., Wilson, I. B., Brown, T. D., Davis, T. E., Smith, L. F., Lober, W. B., McReynolds, J., et al. (2017) · AIDS and Behavior · doi:10.1007/s10461-017-1718-5 · Cited by 33
Feaster, D. J., Mitrani, V. B., Burns, M. J., McCabe, B. E., Brincks, A. M., Rodriguez, A. E., Asthana, D., & Robbins, M. S. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.04.017 · Cited by 32
“Self-report adherence was measured with the AIDS Clinical Trial Group Adherence Interview Questionnaire (Chesney et al., 2000).”
MethodMohr, D. C., Montague, E. N. H., Stiles‐Shields, C., Kaiser, S. M., Brenner, C. J., Palac, H., Carty-Fickes, E., & Duffecy, J. (2015) · EAI Endorsed Transactions on Pervasive Health and Technology · doi:10.4108/icst.pervasivehealth.2015.259042 · Cited by 32
Sangeda, R. Z., Mosha, F. S., Aboud, S., Kamuhabwa, A. A. R., Chalamilla, G., Vercauteren, J., Wijngaerden, E. V., Lyamuya, E., & Vandamme, A. (2018) · Drug Healthcare and Patient Safety · doi:10.2147/dhps.s143178 · Cited by 32
“The most cited reasons for nonadherence were forgetfulness and being away from home as documented also in other studies.(14,21,32,33) In other studies, forgetfulness has being linked to HIV-associated neurocognitive disorders and consequently to nonadherence to ART.”
Agala, C. B., Fried, B. J., Thomas, J. C., Reynolds, H. W., Lich, K. H., Whetten, K., Zimmer, C., & Morrissey, J. P. (2020) · BMC Public Health · doi:10.1186/s12889-020-08585-w · Cited by 36
Norton, W. E., Amico, K. R., Fisher, W. A., Shuper, P. A., Ferrer, R. A., Cornman, D. H., Trayling, C., Redding, C. G., & Fisher, J. D. (2010) · AIDS Care · doi:10.1080/09540121003758630 · Cited by 32
“For the current analysis, we opted to use participants’ self-reports on the VAS rather than the modified three-day AIDS Clinical Trials Group (ACTG) adherence measure (Chesney et al, 2000 ), in order to assess adherence rates over a longer period of time.”
MethodSocial Support and Adherence: Differences Among Clients in an AIDS Day Health Care Program
Gardenier, D., Andrews, C. M., Thomas, D., Bookhardt-Murray, L. J., & Fitzpatrick, J. J. (2009) · Journal of the Association of Nurses in AIDS Care · doi:10.1016/j.jana.2009.06.007 · Cited by 31
“Participants reviewed and corrected chartextracted background data and completed the Social Provision Scale (SPS) (Cutrona & Russell, 1987) and the AIDS Clinical Trial Group (ACTG) adherence follow-up instrument (Chesney et al., 2000).”
MethodRecent cigarette smoking and HIV disease progression: no evidence of an association
Kabali, C., Cheng, D. M., Brooks, D. R., Bridden, C. L., Horsburgh, C. R., & Samet, J. H. (2011) · AIDS Care · doi:10.1080/09540121.2010.542128 · Cited by 32
“ART adherence was measured using the AIDS Clinical Trials Group criteria (Chesney et al., 2000) and defined as a self-report of 100% adherent in the past three days (Samet, Horton, Meli, Freedberg, & Palepu, 2004).”
MethodNambiar, D., Ramakrishnan, V., Kumar, P., Varma, R., Balaji, N., Rajendran, J., Jhona, L., Chandrasekar, C., & Gere, D. (2011) · AIDS Education and Prevention · doi:10.1521/aeap.2011.23.4.351 · Cited by 32
Suleiman, I. A., & Momo, A. (2016) · Pharmacy Practice · doi:10.18549/pharmpract.2016.01.631 · Cited by 32
“The response of missed doses from “too many drugs to take” reinforced results from other studies that have reported HIV medication as an extremely complicated process that requires numerous doses of medication.(33) Studies have also shown that the higher the pill burden, the lower the adherence.”
ResultBezabhe, W. M. M., Bereznicki, L., Chalmers, L., Gee, P. R., Kassie, D. M., Bimirew, M. A., & Peterson, G. M. (2015) · Drug Safety · doi:10.1007/s40264-015-0295-7 · Cited by 31
“Similarly, time adherence was measured using the four-item Likert-type modified ACTG questionnaire [21].”
MethodSocial support and clinical outcomes during antiviral therapy for chronic hepatitis C
Evon, D. M., Esserman, D. A., Ramcharran, D., Bonner, J. E., & Fried, M. W. (2011) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2011.05.003 · Cited by 30
“Medication-taking Adherence (defined by the following two variables) was assessed with a modified version of the Aids Clinical Trial Group Adherence Questionnaire at treatment weeks 4, 12, and 24 for this analysis(29):”
MethodMimiaga, M. J., Kuhns, L. M., Biello, K. B., Olson, J., Hoehnle, S., Santostefano, C. M., Hughto, J. M. W., Safi, H., Salhaney, P., Chen, D., et al. (2018) · BMC Public Health · doi:10.1186/s12889-018-5815-9 · Cited by 31
Nigusso, F. T., & Mavhandu‐Mudzusi, A. H. (2020) · PeerJ · doi:10.7717/peerj.8558 · Cited by 31
Nonadherence is Associated with Lack of HIV-Related Knowledge
Dyrehave, C., Rasmussen, D. N., Hønge, B. L., Jespersen, S., Correia, F. G., Medina, C., Wejse, C. M., Rodkjær, L. Ø., & for the Bissau HIV Cohort Study Group (2015) · Journal of the International Association of Providers of AIDS Care (JIAPAC) · doi:10.1177/2325957415599211 · Cited by 31
“Gender Male 125 (25) 29 (23) Female 369 (75) 94 (25) Age 18-25 26 (5) 5 (20) 26-44 312 (63) 81 (26) 45-64 142 (29) 35 (25) 6512 (2) 2 (17) Employed Yes 87 (18) 18 (21) No 406 (82) 105 (26) Working at home 117 (24) 31 (26) Received salary last month Yes 29 (6) 5 (17) No 465 (94) 118 (25) School Yes 337 (68) 80 (24) No…”
The importance of the patient–clinician relationship in adherence to antiretroviral medication
Molassiotis, A., Morris, K., & Trueman, I. (2007) · International Journal of Nursing Practice · doi:10.1111/j.1440-172x.2007.00652.x · Cited by 31
Non-adherence to anti-retroviral therapy among HIV infected adults in Mon State of Myanmar
Aye, W. L., Puckpinyo, A., & Peltzer, K. (2017) · BMC Public Health · doi:10.1186/s12889-017-4309-5 · Cited by 31
“It is a self-reported ART measure that is simple to use and has been most extensively used [25].”
MethodPeltzer, K., Preez, N. F.-D., Ramlagan, S., Fomundam, H., & Anderson, J. (2010) · African Journal of Traditional Complementary and Alternative Medicines · doi:10.4314/ajtcam.v7i2.50871 · Cited by 31
“The instrument also assesses reasons for non-adherence (Chesney et al., 2000).”
BackgroundCruess, D. G., Minor, S., Antoni, M. H., & Millon, T. (2007) · Journal of Personality Assessment · doi:10.1080/00223890701629805 · Cited by 31
“The validity of the MATI has been established through its association with Medication Event Monitoring System electronic pill monitoring systems and self-reported Adherence to Combination Therapy Guide (Chesney et al., 2000) scores in HAART-treated HIV-infected persons (Llabre et al., 2006).”
MethodAntiretroviral treatment of HIV infection: Swedish recommendations 2007
Josephson, F., Albert, J., Flamholc, L., Gisslén, M., Karlström, O., Lindgren, S.-R., Navér, L., Sandström, E., Svedhem, V., Svennerholm, B., et al. (2007) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540701383154 · Cited by 31
Wilson, T. E., Ickovics, J. R., Fernandez, M. I., Koenig, L. J., & Walter, E. B. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2001.114032 · Cited by 31
Self-citationWang, N., Wang, S., Qian, H.-Z., Ruan, Y., Amico, K. R., Vermund, S. H., Yin, L., Qiu, X., & Zheng, S. (2019) · AIDS Care · doi:10.1080/09540121.2018.1549721 · Cited by 30
“Effective support and treatment for depression and anxiety may also improve medication adherence (Chesney et al., 2000) and self-care more generally.”
BackgroundDeichert, N. T., Fekete, E. M., Boarts, J. M., Druley, J. A., & Delahanty, D. L. (2007) · AIDS and Behavior · doi:10.1007/s10461-007-9214-y · Cited by 30
“Items for this scale were adapted from the General Health Behaviors measure developed by the Adult AIDS Clinical Trials Group [AACTG] (Chesney et al., 2000).”
MethodCook, P. F., Schmiege, S. J., Mansberger, S. L., Sheppler, C. R., Kammer, J. A., Fitzgerald, T., & Kahook, M. Y. (2016) · Psychology and Health · doi:10.1080/08870446.2016.1244537 · Cited by 30
“Studies in other chronic diseases have found three-day recall to be valid based on detection of nonadherence and correlations with known adherence predictors, physiological measures and electronic monitoring (Chesney et al., 2000; Mathews et al., 2004).”
BackgroundWagner, G. J., Linnemayr, S., Goggin, K., Mindry, D. L., Beyeza‐Kashesya, J., Finocchario‐Kessler, S., Robinson, E., Birungi, J., & Wanyenze, R. K. (2017) · AIDS and Behavior · doi:10.1007/s10461-017-1732-7 · Cited by 30
“Social support was measured with a single item from the ACTG assessment battery [29]; respondents rated their agreement with the statement, ‘‘I can count on my family and friends to give me the support I need’’ using a scale of 1 ‘strongly disagree’ to 5 ‘strongly agree’.”
MethodCarrieri, P., Protopopescu, C., Marcellin, F., Rosellini, S., Wittkop, L., Esterle, L., Zucman, D., Raffi, F., Rosenthal, É., Poizot‐Martin, I., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.08.005 · Cited by 30
Tassiopoulos, K., Huo, Y., Patel, K., Kacanek, D., Allison, S. M., Siminski, S. M., Nichols, S., Mellins, C. A., (PHACS), P. H. C. S., Yogev, R., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz747 · Cited by 33
Préau, M., Protopopescu, C., Raffi, F., Rey, D., Chêne, G., Marcellin, F., Perronne, C., Ragnaud, J. M., Leport, C., Spire, B., et al. (2011) · AIDS Care · doi:10.1080/09540121.2011.613909 · Cited by 30
Kremer, H., & Ironson, G. H. (2006) · AIDS Care · doi:10.1080/09540120600766020 · Cited by 30
“Although these are consistent with other reports (Chesney et al., 2000; Gallant & Block, 1998; Golin et al., 2002; Walsh et al., 2001), as we note above, patients often don’t disclose their physicians why they are missing doses*how then can the physician encourage the patient to communicate this…”
BackgroundResultFletcher, F. E., Vidrine, D. J., Tamí‐Maury, I., Danysh, H. E., King, R. M., Buchberg, M. K., Arduino, R. C., & Gritz, E. R. (2013) · AIDS and Behavior · doi:10.1007/s10461-013-0480-6 · Cited by 33
Herrmann, S., Wardrop, J., John, M., Gaudieri, S., Lucas, M., Mallal, S. A., & Nolan, D. A. (2012) · Sexual Health · doi:10.1071/sh11181 · Cited by 30
Holstad, M. M., Foster, V., DiIorio, C. K., McCarty, F., & Teplinskiy, I. (2009) · Journal of the Association of Nurses in AIDS Care · doi:10.1016/j.jana.2009.08.002 · Cited by 30
“Although they have established validity (Chesney et al., 2000), the instruments have some limitations.”
BackgroundMethodInfluentialIronson, G. H., Balbin, E., Stieren, E. S., Detz, K., FLETCHER, M. A., Schneiderman, N., & Kumar, M. (2008) · International Journal of Behavioral Medicine · doi:10.1080/10705500802219606 · Cited by 31
“Adherence was measured by the AIDS Clinical Trials Group questionnaire (ACTG: Chesney et al., 2000), which asks about medications prescribed and missed doses.”
MethodJohnson, M. O., Sevelius, Dilworth, Saberi, & Neilands (2012) · Patient Preference and Adherence · doi:10.2147/ppa.s30040 · Cited by 30
Patient-Level Medication Regimen Complexity in Patients With HIV
Metz, K. R., Fish, D. N., Hosokawa, P. W., Hirsch, J. D., & Libby, A. M. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014539642 · Cited by 30
“”(10) Thus, patient-level medication regimen complexity has special importance to the HIV-infected patient because strict adherence to cART therapies is considered critical to clinical effectiveness.(6,11,12) We sought to assess patient-level medication regimen complexity for patients with treated HIV as a surrogate m…”
BackgroundSampaio-Sa, M., Page, K. A., Bangsberg, D. R., Evans, J. L., Dourado, M. D. L., Teixeira, C., Netto, E. M., & Brites, C. R. (2008) · AIDS and Behavior · doi:10.1007/s10461-008-9414-0 · Cited by 30
“The AIDS Clinical Trial Group (ACTG) adherence questionnaires (Chesney et al. 2000) were adapted for use after translation and piloting in our clinical population.”
Adherence, H. H. A. T. (2004) · AIDS Care · doi:10.1080/09540120412331315312 · Cited by 30
Singh, H., Dulhani, N., Tiwari, P., Singh, P. K., & Sinha, T. (2009) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.58512 · Cited by 29
de Almeida, C. A. F., & Benatti, M. C. C. (2007) · Revista da Escola de Enfermagem da USP · doi:10.1590/s0080-62342007000100016 · Cited by 29
Horvath, K. J., Amico, K. R., Erickson, D. J., Ecklund, A. M., Martinka, A., DeWitt, J., McLaughlin, J., & Parsons, J. T. (2018) · JMIR Research Protocols · doi:10.2196/10182 · Cited by 29
“Next, items adapted from Adult AIDS Clinical Trials Group [34] and from a more recent study by Wilson and colleagues assessing the validity of an ART adherence scale [35] are used to assess aspects of self-reported ART adherence.”
MethodMabunda, K., Ngamasana, E. L., Babalola, J. O., Zunza, M., & Nyasulu, P. S. (2019) · Pan African Medical Journal · doi:10.11604/pamj.2019.32.37.17722 · Cited by 33
Newcomb, M. E., Sarno, E. L., Bettin, E., Carey, J., Ciolino, J. D., Hill, R., Garcia, C. P., Macapagal, K. R., Mustanski, B. S., Swann, G., et al. (2019) · JMIR Research Protocols · doi:10.2196/15883 · Cited by 29
“undetectable) [65] ARTc adherence and viral suppression”
Feaster, D. J., Brincks, A. M., Mitrani, V. B., Prado, G. J., Schwartz, S. J., & Szapocznik, J. (2010) · Journal of Family Psychology · doi:10.1037/a0017954 · Cited by 29
“Medication Adherence—Adherence was measured using the AIDS Clinical Trial Group Adherence Interview Questionnaire (Chesney et al., 2000).”
MethodAging With HIV in the Era of Antiretroviral Treatment
Nideröst, S., & Imhof, C. (2016) · Gerontology and Geriatric Medicine · doi:10.1177/2333721416636300 · Cited by 29
Life Lessons from Women with HIV: Mutuality, Self-Awareness, and Self-Efficacy
Brody, L. R., Jack, D. C., Bruck-Segal, D., Ruffing, E. G., Firpo-Perretti, Y. M., Dale, S. K., Weber, K. M., & Cohen, M. H. (2016) · AIDS Patient Care and STDs · doi:10.1089/apc.2016.0031 · Cited by 29
Da, W., Li, X., Qiao, S., Zhou, Y., & Shen, Z. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203032 · Cited by 32
Desenvolvimento de uma escala de auto-eficácia para adesão ao tratamento anti-retroviral
Leite, J. C. D. C., Drachler, M. D. L., Centeno, M. O., Pinheiro, C. A. T., & da Silveira, V. L. (2002) · Psicologia Reflexão e Crítica · doi:10.1590/s0102-79722002000100014 · Cited by 30
Lightfoot, M. A., Rogers, T., Goldstein, R. B., Rotheram‐Borus, M. J., May, S. J., Kirshenbaum, S. B., Weinhardt, L. S., Zadoretzky, C., Kittel, L., Johnson, M. O., et al. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.07.009 · Cited by 29
A Qualitative Study of Literacy and Patient Response to HIV Medication Adherence Questionnaires
Wolf, M. S., Bennett, C. L., Davis, T. C., Marin, E., & Arnold, C. L. (2005) · Journal of Health Communication · doi:10.1080/10810730500228631 · Cited by 29
“…fact that only a few of the available instruments have documented validity and reliability testing, and none were evaluated specifically among patients with lower educational attainment or limited literacy skills (Chesney et al., 2000; Collier et al., 1996; Duong et al., 2001; Eldred et al., 1998).”
BackgroundRussell, C. K., Bunting, S. M., Graney, M. J., Hartig, M. T., Kisner, P., & Brown, B. (2003) · Journal of the Association of Nurses in AIDS Care · doi:10.1177/1055329003255114 · Cited by 29
“One study found that 72% of patients took their medicine 80% of the time (Laurence, 2001), whereas a survey of 76 patients in an AIDS clinical trial group found that 18% of participants had missed doses in the last 2 days and 36% had missed doses in the last 2 weeks (Chesney et al., 2000).”
BackgroundFactores predictores de no adherencia al tratamiento antirretroviral de gran actividad*
Martín, V., de Leóng, E. G. D. T. S. A. A. T. E. L. P., Ortega-Valín, L., Pérez-Simón, M. R., Mostaza-Fernández, J. L., de Urbina‐González, J. J. O., Rodríguez-María, M., Carro-Fernández, J. A., Cuevas-González, M. J., & Alcoba-Leza, M. (2002) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(02)72851-6 · Cited by 29
Evon, D. M., Esserman, D. A., Bonner, J. E., Rao, T., Fried, M. W., & Golin, C. E. (2013) · Journal of Viral Hepatitis · doi:10.1111/jvh.12079 · Cited by 28
Orkin, C. M., Cahn, P. E., Castagna, A., Emu, B., Harrigan, P. R., Kuritzkes, D. R., Nelson, M. R., & Schapiro, J. (2022) · HIV Medicine · doi:10.1111/hiv.13288 · Cited by 28
Gender Differences in Determinants of Condom Use Among HIV Clients in Uganda
Walusaga, H., Kyohangirwe, R., & Wagner, G. J. (2012) · AIDS Patient Care and STDs · doi:10.1089/apc.2012.0208 · Cited by 28
Garcia, R., Badaró, R. J. D. S., Netto, E. M., Silva, M. V. D. S., Amorin, F. S., Ramos, A. I. N., Vaida, F., Brites, C. R., & Schooley, R. T. (2006) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2006.22.1248 · Cited by 28
Harzke, A. J., Williams, M. L., Schönnesson, L. N., Ross, M. W., Timpson, S. C., & Keel, K. B. (2004) · AIDS Care · doi:10.1080/09540120410001683394 · Cited by 28
The ABCs of Trait Anger, Psychological Distress, and Disease Severity in HIV
McIntosh, R. C., Hurwitz, B. E., Antoni, M. H., Gonzalez, A., Seay, J., & Schneiderman, N. (2014) · Annals of Behavioral Medicine · doi:10.1007/s12160-014-9667-y · Cited by 28
“This self-report retrospective measure is commonly used in the HIV literature (54).”
MethodJacobs, R. J., Caballero, J., Ownby, R. L., & Kane, M. N. (2014) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-014-0103-9 · Cited by 28
Reznick, O. G., McCartney, K., Gregorich, S. E., Zack, B., & Feaster, D. J. (2013) · Journal of Correctional Health Care · doi:10.1177/1078345813486442 · Cited by 27
“…participants were asked to name their currently prescribed antiretroviral medications, the prescribed dosing schedule, and the number of doses they actually took during each of the prior 3 days using a modified version of the AIDS Clinical Trials Group questionnaire (Chesney et al., 2000).”
MethodJohns Hopkins University Bloomberg School of Public Health MPH Capstone Project
Gebo, K. A. (2005) · Cited by 28
Effects of Sleep Health on Cognitive Function in HIV+ and HIV– Adults
Mahmood, Z., Hammond, A., Núñez, R. A., Irwin, M. R., & Thames, A. D. (2018) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617718000607 · Cited by 28
“The AIDS Clinical Trials Group (ACTG; Chesney et al., 2000) Adherence Baseline Questionnaire was also administered and current depression was assessed by the Beck Depression Inventory-2, with the sleep item excluded from the total score [BDI-II; Beck, Steer, & Brown, 1996]).”
MethodOutpatient pharmacy care and HIV viral load response among patients on HAART
Castillo, E., Palepu, A., Beardsell, A., Akagi, L., Yip, B., Montaner, J. S. G., & Hogg, R. S. (2004) · AIDS Care · doi:10.1080/09540120410001683385 · Cited by 28
Joshi, B. N., Chauhan, S., Pasi, A. R., Kulkarni, R. N., Sunil, N., Bachani, D., & Mankeshwar, R. (2014) · Europe PMC (PubMed Central) · Cited by 27
Relationship quality among HIV patients and their caregivers
Miller, I. W., Bishop, D. S., Herman, D. S., & Stein, M. D. (2006) · AIDS Care · doi:10.1080/09540120600624278 · Cited by 27
“To maximise recall and minimise potential bias, we assessed the patients adherence to HIV treatment over the past four days (Chesney et al., 2000).”
MethodChawana, T. D., Gandhi, M., Nathoo, K., Ngara, B., Louie, A., Horng, H., Katzenstein, D. A., Metcalfe, J. Z., Nhachi, C. F. B., & Adolescent Treatment Failure (ATF) study team (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001452 · Cited by 27
A qualitative study of patients’ experience of recovery after a distal femoral fracture
Phelps, E. E., Tutton, E., Griffin, X. L., & Baird, J. (2019) · Injury · doi:10.1016/j.injury.2019.07.021 · Cited by 27
“Low levels of self-efficacy are associated with less optimal health behaviours such as poorer adherence to medicine[19, 20], unhealthy food intake [21] and poorer vaccine uptake [22].”
BackgroundOptimizing the Analysis of Adherence Interventions Using Logistic Generalized Estimating Equations
Huh, D., Flaherty, B. P., & Simoni, J. M. (2011) · AIDS and Behavior · doi:10.1007/s10461-011-9955-5 · Cited by 27
“Past three-day dose ARV adherence was assessed using a modified version of the Adult AIDS Clinical Trial Group Instrument [20].”
MethodStimulant Use and HIV Disease Management Among Men in Same-Sex Relationships
Carrico, A., Woolf-King, S., Neilands, T., Dilworth, S., & Johnson, M. O. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.03.025 · Cited by 21
Hanif, H., Bastos, F. I., Malta, M., Bertoni, N., Surkan, P. J., WINCH, P. J., & Kerrigan, D. L. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-574 · Cited by 28
Intentional and unintentional nonadherence in patients prescribed HAART treatment regimens
Wroe, A., & Thomas, M. (2003) · Psychology Health & Medicine · doi:10.1080/1354850310001604595 · Cited by 27
“It has also been reported that complicated and confusing pill regimens, together with busy and inconsistent daily lifestyles are common reasons for missing treatment doses (Chesney et al., 2000).”
BackgroundAtkinson, J. S., Schönnesson, L. N., Williams, M. L., & Timpson, S. C. (2008) · AIDS Care · doi:10.1080/09540120701506788 · Cited by 27
“It has been associated with adherence in studies by Catz et al. (2000); Chesney et al. (2000); Gifford et al. (2000); Molassiotis et al. (2002); Godin et al. (2005); and Nilsson Schönnesson et al. (2006).”
ResultAdherence to highly active antiretroviral therapy in a tertiary care hospital in West Bengal, India
Saha, I., Saha, I., Sarkar, A., Das, D., Misra, R., Bhattacharya, K., Roy, R., & Bhattacharya, A. (2014) · Singapore Medical Journal · doi:10.11622/smedj.2014021 · Cited by 27
for the CHARTER Group, Hammond, E. R., Crum, R. M., Treisman, G. J., Mehta, S. H., Clifford, D. B., Ellis, R. J., Gelman, B. B., Grant, I., Letendre, S. L., et al. (2016) · Journal of NeuroVirology · doi:10.1007/s13365-015-0416-1 · Cited by 27
“…RNA levels, cognitive impairment assessed by the Global Deficit Score (GDS) (Carey et al. 2004), a summary measure of the standardized comprehensive neurocognitive assessment, and medication adherence assessed by the AIDS Clinical Trials Group 4-Day Adherence Questionnaire (Chesney et al. 2000).”
Influential
Metadata
- Authors
- Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., Wu, A. W., & PATIENT CARE COMMITTEE & ADHERENCE
- Affiliations
- University of California, San Francisco (US)
- Yale University (US)
- University of California San Diego (US)
- The Ohio State University (US)
- Indiana University Indianapolis (US)
- Johns Hopkins University (US)
- Venue
- AIDS Care
- Publisher
- Informa UK Limited
- Published
- 2000-06
- Volume
- 12
- Issue
- 3
- Pages
- 255-266
- ISSN
- 0954-0121 (ISSN-L)
- 1360-0451
- OpenAlex
- W2088423598
- Cited by
- 1,428
- References
- 12
- Citations by year
- 2026: 14 · 2025: 28 · 2024: 29 · 2023: 29 · 2022: 40 · 2021: 53 · 2020: 51 · 2019: 55 · 2018: 61 · 2017: 66 · 2016: 67 · 2015: 76 · 2014: 81 · 2013: 84 · 2012: 74
- FWCI
- 27.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- AIDS Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (P50-MH42459, P30MH059037, P50MH042459, P30-MH 59037)
- National Institute of Allergy and Infectious Diseases (U01AI-38858, U01AI038858)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Keywords
- antiretroviral therapy adherence, HIV, self-report questionnaire, medication non-adherence, adherence self-efficacy, alcohol consumption, protease inhibitors, clinical trial participants, questionnaire development
- MeSH terms
- Adult, Alcohol Drinking, Clinical Trials as Topic, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Patient Compliance, Pilot Projects, Surveys and Questionnaires, Risk Factors, Socioeconomic Factors, HIV Infections, Anti-HIV Agents, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review